NCT05682092 is a NA clinical trial of WonderLab Collagen Tripeptide Drink in Skin Laxity, sponsored by Shenzhen Precision Health Food Technology Co. Ltd.,.

Who is sponsoring NCT05682092?

NCT05682092 is sponsored by Shenzhen Precision Health Food Technology Co. Ltd.,.

What drugs are being tested in NCT05682092?

Interventions in NCT05682092: WonderLab Collagen Tripeptide Drink, Ordinary Drink.

What condition does NCT05682092 study?

NCT05682092 studies Skin Laxity, Skin Fold.

Is NCT05682092 still recruiting?

NCT05682092 is currently completed. Last updated 12 April 2023.

Last reviewed 2023-04-12 · How we verify

NCT05682092

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Collagen Efficacy on Skin Anti-aging in 30 to 50-Year-Old Women

Completed NA Last updated 12 April 2023

What this trial tests

NA trial testing WonderLab Collagen Tripeptide Drink in Skin Laxity in 70 participants. Completed in 31 March 2023.

Timeline

16 January 2023

Primary endpoint
12 March 2023

31 March 2023

Quick facts

Lead sponsor	Shenzhen Precision Health Food Technology Co. Ltd.,
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	70
Start date	16 January 2023
Primary completion	12 March 2023
Estimated completion	31 March 2023
Sites	2 locations across China

Drugs / interventions tested

WonderLab Collagen Tripeptide Drink
Ordinary Drink

Conditions studied

Skin Laxity — all drugs for Skin Laxity →
Skin Fold — all drugs for Skin Fold →

Sponsor

Shenzhen Precision Health Food Technology Co. Ltd.,

Who can join

Adults 30 to 50, female only, with Skin Laxity or Skin Fold. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This goal of this clinical trial is to study the efficacy of collagen supplement on skin moisture and elasticity in middle-aged women of 30-50 years old. Participants will be assigned two products with and without collagen supplement and use for 2 months, twice a day. Researchers will compare the two groups whether there are siginificant improvement of skin moisture and elasticity for participants via skin measurement and anaysis system.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise.
Tenchov R, Sasso JM, Wang X, Zhou QA. · · 2024 · cited 23× · PMID 38214973 · DOI 10.1021/acschemneuro.3c00532
Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other recruiting trials for Skin Laxity

Currently open trials in the same condition.

NCT07224880 — Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 R · recruiting
NCT06941610 — An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity · NA · recruiting
NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting
NCT06603194 — Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults · NA · recruiting
NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting

Other Shenzhen Precision Health Food Technology Co. Ltd., trials

Trials by the same sponsor.

NCT06030999 — The Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics · NA · completed
NCT05900752 — A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients · NA · completed
NCT05756712 — The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test · NA · completed
NCT05696938 — Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50- Year-old Women · NA · completed
NCT05710055 — The Efficacy on Overweight With Oral Supplemenation of Probiotics and Prebiotics · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05682092 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shenzhen Precision Health Food Technology Co. Ltd.,
Last refreshed: 12 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05682092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing